Capricor Therapeutics Stockholders Facing Losses Urged to Contact Robbins LLP
Investors who have experienced significant losses in Capricor Therapeutics stock are being advised to contact Robbins LLP ahead of the September 28, 2026 lead plaintiff deadline.
Robbins LLP, a law firm specializing in securities litigation, has announced that a class action lawsuit has been filed on behalf of individuals and entities who purchased or acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025, and July 26, 2026.
The lawsuit alleges that Capricor Therapeutics may have issued misleading statements regarding its business operations and future prospects during the specified period. Investors who have suffered substantial financial losses due to their investment in CAPR stock are encouraged to seek legal counsel.
The deadline for potential lead plaintiffs to file their claims with the court is September 28, 2026. Robbins LLP is investigating the matter and is offering free consultations to affected shareholders.
Shareholders interested in learning more about the lawsuit and their options are advised to contact Robbins LLP directly for further information.